Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Kenna

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Toxicology and Applied Pharmacology|October 22, 2024
In vitro pharmacologic profiling aids systemic toxicity assessment of chemicalsMatthew Burbank, Predrag Kukic, Gladys Ouedraogo, et al.
Regulatory Toxicology and Pharmacology : RTP|January 6, 2022
A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessmentCamilla Alexander-White, Dagmar Bury, Mark Cronin, et al.
Magma (New York, N.Y.)|August 6, 2024
Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility studyEbony R Gunwhy, Catherine D G Hines, Claudia Green, et al.
Archives of Toxicology|April 24, 2013
In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acidAlison V M Rodrigues, Helen E Rollison, Scott Martin, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2014
Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonistsJ Gerry Kenna, Simone H Stahl, Julie A Eakins, et al.
Toxicology and Applied Pharmacology|June 16, 2009
Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: Induction of cell defence, apoptosis and hepatic necrosisAmy E Mercer, Sophie L Regan, Charlotte M Hirst, et al.
Chemical Research in Toxicology|June 1, 2012
In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugsRichard A Thompson, Emre M Isin, Yan Li, et al.
Pharmaceutics|March 29, 2023
Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug-Drug Interactions in RatsNicola Melillo, Daniel Scotcher, J Gerry Kenna, et al.
Sensors (Basel, Switzerland)|November 1, 2014
Fabrication and evaluation of a micro(bio)sensor array chip for multiple parallel measurements of important cell biomarkersRoy M Pemberton, Timothy Cox, Rachel Tuffin, et al.
Biomed Research International|October 1, 2016
Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansFranck A Atienzar, Eric A Blomme, Minjun Chen, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Toxicology and Applied Pharmacology|October 22, 2024
In vitro pharmacologic profiling aids systemic toxicity assessment of chemicalsMatthew Burbank, Predrag Kukic, Gladys Ouedraogo, et al.
Regulatory Toxicology and Pharmacology : RTP|January 6, 2022
A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessmentCamilla Alexander-White, Dagmar Bury, Mark Cronin, et al.
Magma (New York, N.Y.)|August 6, 2024
Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility studyEbony R Gunwhy, Catherine D G Hines, Claudia Green, et al.
Archives of Toxicology|April 24, 2013
In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acidAlison V M Rodrigues, Helen E Rollison, Scott Martin, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2014
Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonistsJ Gerry Kenna, Simone H Stahl, Julie A Eakins, et al.
Toxicology and Applied Pharmacology|June 16, 2009
Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: Induction of cell defence, apoptosis and hepatic necrosisAmy E Mercer, Sophie L Regan, Charlotte M Hirst, et al.
Chemical Research in Toxicology|June 1, 2012
In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugsRichard A Thompson, Emre M Isin, Yan Li, et al.
Pharmaceutics|March 29, 2023
Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug-Drug Interactions in RatsNicola Melillo, Daniel Scotcher, J Gerry Kenna, et al.
Sensors (Basel, Switzerland)|November 1, 2014
Fabrication and evaluation of a micro(bio)sensor array chip for multiple parallel measurements of important cell biomarkersRoy M Pemberton, Timothy Cox, Rachel Tuffin, et al.
Biomed Research International|October 1, 2016
Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansFranck A Atienzar, Eric A Blomme, Minjun Chen, et al.
Pageof 5